Major Highlights for Month of July 2014: IPM clocked 7161 Crs in July 2014
Indian Pharma Market grew at 7.2% for the month of July 2010
For the month of July 2014, among the top 10, Sun Pharma grew by 14.2%, Lupin by 13.2% & Cipla at 9.5%
Macleods grew at 27.9% to be the 10th biggest corporate for the month of July 2014
With the Portfolio of Elder, Torrent is now placed at 16th rank in IPM.
24 co's have crossed the growth of IPM for the month of July 2014 among top 50
Among the top 50 Co's, Akumentis has the highest growth of 49.0% followed by Ajanta at 41.2% & Apex at 40.9%
16 Co's showed double digit growths among the top 50
Among the 11-20 ranked co's Macleods has the highest growth of 27.9% followed by Ipca at 21.2% & Aristo at 16.2%
Among the 51-60 ranked co's, Panacea grows at 36.9% followed by Troikaa at 22.3 & Systopic 20.3%
Among the 61-75 ranked co's, Lincoln grew at 43.7% followed by Corona at 36.3% & Serdia at 19.6%
Indian V/S MNCs:
Indian companies have grown at 9.1% versus 1.5% for MNCs in July 2014
Among the top 50 MNCs, MSD & Janssen grew at 6.9% and Ranbaxy at 5.7%
Under the Non-NLEM category Indian Companies degrew at 11.1% whereas MNCs degrew at 2.5%
DPCO V/s Non DPCO Market:
The DPCO 2013 containing molecules market was at –0.7% whereas the non DPCO market grew by 8.90% resulting in an overall growth of 7.2% for July 2014
NLEM Category showed positive unit growth at 3.2%
The DPCO 2013 portfolio for Pfizer degrew at 16.7%, GSK degrew at 7.9% & Ranbaxy grew by 18.2%.
Source: AIOCD Pharmasofttech AWACS